Keshi Chen

Dr. Keshi Chen

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2010 in Cell Stem Cell
Verified
Journal Article
Closed access
MEMiguel Angel Esteban
Miguel Angel Esteban
TWTao Wang
Tao Wang
BQBaoming Qin
Baoming Qin
JYJiayin Yang
Jiayin Yang
DQDajiang Qin
Dajiang Qin
DPDuanqing Pei
Duanqing Pei

1 December 2011 in Cell Stem Cell
Verified
Journal Article
Closed access
TWTao Wang
Tao Wang
KCKeshi Chen
Keshi Chen
XZXiaoming Zeng
Xiaoming Zeng
JYJianguo Yang
Jianguo Yang
YWYun Wu
Yun Wu
DPDuanqing Pei
Duanqing Pei

24 August 2020 in Nature Metabolism
Verified
Journal Article
Closed access
PDF file
LLLinpeng Li
Linpeng Li
KCKeshi Chen
Keshi Chen
TWTianyu Wang
Tianyu Wang
YWYi Wu
Yi Wu
GXGuangsuo Xing
Guangsuo Xing
Xingguo LiuXingguo Liu
Xingguo Liu

20 January 2015 in Hepatology
Verified
Journal Article
Open access
PDF file
SLShengbiao Li
Shengbiao Li
JGJingyi Guo
Jingyi Guo
ZYZhongfu Ying
Zhongfu Ying
SCShen Chen
Shen Chen
LYLiang Yang
Liang Yang
Xingguo LiuXingguo Liu
Xingguo Liu
Valproic acid (VPA) is widely used to treat epilepsy, migraine, chronic headache, bipolar disorder, and as adjuvant chemotherapy, but potentially causes idiosyncratic liver injury. Alpers‐Huttenlocher syndrome (AHS), a neurometabolic disorder caused by mutations in mitochondrial DNA polymerase gamma (POLG), is associated with an increased risk of developing fatal VPA hepatotoxicity. However, the mechanistic link of this clinical mystery remains unknown. Here, fibroblasts from 2 AHS patients were reprogrammed to induced pluripotent stem cells (iPSCs) and then differentiated to hepatocyte‐like cells (AHS iPSCs‐Hep). Both AHS iPSCs‐Hep are more sensitive to VPA‐induced mitochondrial‐dependent apoptosis than controls, showing more activated caspase‐9 and cytochrome c release. Strikingly, levels of both soluble and oligomeric optic atrophy 1, which together keep cristae junctions tight, are reduced in AHS iPSCs‐Hep. Furthermore, POLG mutation cells show reduced POLG expression, mitochondrial DNA (mtDNA) amount, mitochondrial adenosine triphosphate production, as well as abnormal mitochondrial ultrastructure after differentiation to hepatocyte‐like cells. Superoxide flashes, spontaneous bursts of superoxide generation, caused by opening of the mitochondrial permeability transition pore (mPTP), occur more frequently in AHS iPSCs‐Hep. Moreover, the mPTP inhibitor, cyclosporine A, rescues VPA‐induced apoptotic sensitivity in AHS iPSCs‐Hep. This result suggests that targeting mPTP opening could be an effective method to prevent hepatotoxicity by VPA in AHS patients. In addition, carnitine or N‐acetylcysteine, which has been used in the treatment of VPA‐induced hepatotoxicity, is able to rescue VPA‐induced apoptotic sensitivity in AHS iPSCs‐Hep. Conclusion: AHS iPSCs‐Hep are more sensitive to the VPA‐induced mitochondrial‐dependent apoptotic pathway, and this effect is mediated by mPTP opening. Toxicity models in genetic diseases using iPSCs enable the evaluation of drugs for therapeutic targets. (Hepatology 2015;61:1730‐1739)

25 May 2022 in Cell Death & Differentiation
Verified
Journal Article
Closed access
PDF file
YWYi Wu
Yi Wu
KCKeshi Chen
Keshi Chen
LLLinpeng Li
Linpeng Li
ZHZhihong Hao
Zhihong Hao
TWTianyu Wang
Tianyu Wang
Xingguo LiuXingguo Liu
Xingguo Liu

1 November 2019 in Science Advances
Verified
Journal Article
Open access
PDF file
YWYi Wu
Yi Wu
KCKeshi Chen
Keshi Chen
GXGuangsuo Xing
Guangsuo Xing
LLLinpeng Li
Linpeng Li
BMBochao Ma
Bochao Ma
Xingguo LiuXingguo Liu
Xingguo Liu
Phospholipid-dependent regulation of NF-κB contributes to mesenchymal-to-epithelial transition in pluripotency acquisition.